Amyloid-directed monoclonal antibodies for the treatment of Alzheimer's disease: the point of no return? (Q38224958)

From Wikidata
Jump to navigation Jump to search
scientific article published on 30 June 2014
edit
Language Label Description Also known as
English
Amyloid-directed monoclonal antibodies for the treatment of Alzheimer's disease: the point of no return?
scientific article published on 30 June 2014

    Statements

    Amyloid-directed monoclonal antibodies for the treatment of Alzheimer's disease: the point of no return? (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit